The same authors reported that PAR/JTB expression was upregulated in all studied prostatic carcinoma cell lines compared with normal prostatic tissue, in androgen-resistant prostate cancer cell lines in comparison with androgen-sensitive prostate cells, in MCF7 and T47D BC cell lines, as well as in all the primary breast tumors studied compared to their normal counterparts. This evidence concerns the gene JTB and breast cancer.